mAbxience will open its first European facility on October 16th. Located in León, its facility has a 16.000m2 surface and is equipped with the most advanced technology for each of its processes. Reason for which, its poised to become a biosimilar development and manufacturing benchmark.
The opening act will take place at “Parque Tecnológico de León” and will count on the attendance of policy, economic, scientific and health authorities